Patients with a germline TP53 pathogenic variant typically develop high grade (2 or 3), HER2 positive, infiltrating ductal carcinoma, confirming our previously reported observation and subsequent reports from other groups 11, 12, 13. The gene discussed is ERBB2; the disease is invasive ductal breast carcinoma.